Search hospitals
>
Minnesota
>
Minneapolis
University of Minnesota/Masonic Cancer Center
Claim this profile
Minneapolis, Minnesota 55455
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Lymphoma
Conducts research for Acute Myelogenous Leukemia
Conducts research for Solid Tumors
723 reported clinical trials
35 medical researchers
Summary
University of Minnesota/Masonic Cancer Center is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Cancer, Leukemia, Lymphoma, Acute Myelogenous Leukemia, Solid Tumors and other specialties. University of Minnesota/Masonic Cancer Center is involved with conducting 723 clinical trials across 720 conditions. There are 35 research doctors associated with this hospital, such as Emily Greengard, Manish Patel, Christopher Moertel, and Peter M. Gordon.
Area of expertise
Cancer
University of Minnesota/Masonic Cancer Center has run 122 trials for Cancer. Some of their research focus areas include:
Leukemia
University of Minnesota/Masonic Cancer Center has run 105 trials for Leukemia. Some of their research focus areas include:
Top PIs
Emily Greengard
University of Minnesota/Masonic Cancer Center
6 years of reported clinical research
Manish Patel
Florida Cancer Specialists
2 years of reported clinical research
Christopher Moertel
University of Minnesota/Masonic Cancer Center
6 years of reported clinical research
Peter M. Gordon
University of Minnesota/Masonic Cancer Center
6 years of reported clinical research
Clinical Trials running at University of Minnesota/Masonic Cancer Center
Skin Cancer
Cancer
Lung Cancer
Ovarian Cancer
Acute Lymphoblastic Leukemia
Brain Tumor
Leukemia
Non-Hodgkin's Lymphoma
Neuroblastoma
Myelodysplastic Syndrome
Cemiplimab + Surgery
for Advanced Skin Cancer
This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed by surgery (resectable) and that may have come back after a period of improvement (recurrent). The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cemiplimab has been approved for the treatment of skin cancer that has spread or that cannot be removed by surgery, but it has not been approved for the treatment of skin cancer than can be removed by surgery. Adding cemiplimab to the usual treatment of surgery with or without radiation may be more effective in treating patients with stage III/IV resectable squamous cell skin cancer than the usual treatment alone.
Recruiting
2 awards
Phase 3
7 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Minnesota/Masonic Cancer Center?
University of Minnesota/Masonic Cancer Center is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Cancer, Leukemia, Lymphoma, Acute Myelogenous Leukemia, Solid Tumors and other specialties. University of Minnesota/Masonic Cancer Center is involved with conducting 723 clinical trials across 720 conditions. There are 35 research doctors associated with this hospital, such as Emily Greengard, Manish Patel, Christopher Moertel, and Peter M. Gordon.
Where is University of Minnesota/Masonic Cancer Center located?
**Masonic Cancer Center, University of Minnesota Health Clinics and Surgery Center** - **Location:** 425 E River Pkwy, Minneapolis, MN 55455. - **Directions:** From I-35W south, take Highway 280 south to I-94W, then continue to Huron Boulevard. - **City:** Minneapolis, MN.
Who should I call to ask about financial aid or insurance network?
The University of Minnesota/Masonic Cancer Center offers several contact options for financial assistance and insurance queries: - For general payment inquiries, contact the Community-University Health Care Center (CUHCC) at 612-301-3433. - For cancer-related insurance guidance, reach out to the Masonic Cancer Clinic's Cancer Information Nurse Line at 612-624-2620. - To schedule appointments, call 612-676-4200, and for hematology and oncology services referrals, contact M Health Fairview Cancer Care at 855-486-7226.
What insurance does University of Minnesota/Masonic Cancer Center accept?
The University of Minnesota Physicians encourage patients to understand their insurance coverage, benefits, and out-of-pocket costs before visiting. For detailed information on accepted insurance plans, contact the University of Minnesota/Masonic Cancer Center directly or visit their official website.
What awards or recognition has University of Minnesota/Masonic Cancer Center received?
The Masonic Cancer Center at the University of Minnesota, located in Minneapolis, Minnesota, is a National Cancer Institute-designated comprehensive cancer center since 1998. It is recognized for its outstanding research and care. The center has also been awarded a $5.1 million grant by the National Institute of Environmental Health Sciences to research the impact of environmental factors on cancer.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.